Figure 1 | Scientific Reports

Figure 1

From: TP53 mutants and non-HPV16/18 genotypes are poor prognostic factors for concurrent chemoradiotherapy in locally advanced cervical cancer

Figure 1

Clinicopathological factors and mutation profile (more than 5% frequency) in our cohort. (A) Clinical factors, histological types, and recurrence status; (B) HPV genotype and IHC staining pattern; and (C) mutation profile of the seventy patients with cervical cancer. Mutated genes are color-coded according to their mutation type. Data analysis was carried out using the Torrent Suite Software v5.0.4 (Thermo Fisher Scientific).

Back to article page